Although, SNDX-ms6352 alone efficiently depleted F4/80+ TAMs in T12 tumors via cleaved caspase-3 activation it had little to no impact on primary tumor growth (Figures S1D–S1G). The gene discussed is CASP3; the disease is neoplasm.